• A comprahensive training package for those involved in healthcare technology commercialisation will be launched soon watch this space #
• When thinking about medical devices marketing is so much more important than with drugs! Route to market needs to be in you development plan #
• New business support website to be launched soon! Helping consultants profit maximise! #

Powered by Twitter Tools

• Choice of regulator for scientific advice is not as simple as it looks! Agencies that approve you CTA might not do you marketing license! #
• Flexibility is key when dealing with regulators! #

Powered by Twitter Tools

• Licensing can be simple when you proposition is simple and the technology is a fit with current activites, without that its challenging #
• Keeping ontop of admin can be damed demanding but all too esential, its like taking time to learn new things! #
• Herbal medicines are a very important part of the medicine cabinet! Our experts can get yours to market with minimal fuss and expense! #
• Framework programmes require some signigicant investment of time and experise in order to acheive success! You need the right team! #

Powered by Twitter Tools

• Whilst a methodical process is esential, sometimes asking an expert for a gut feel can slash months of time and expense from a project! #
• Opportunities come along that give you a chance to share your expertise with a huge number of people! Take them and run with it. #
• New FDA non clinical guidlines! Video review available later today! Go to http://www.damienbove.com and click on reports! #
• Development can take longer than expected, discovery more so than development, but don't make the error or not having a plan! #

Powered by Twitter Tools

• You can know more about clinical trial design then any man alive! But until you speak to the clinical staff and gage feasibilty, its nothing #
• If the villigers are going around burning houses with an X on the door! Don't paint an X on you door, or even a Y, it looks too like a X #

Powered by Twitter Tools

• I'v been writing an FDA orphan application all day! Just a minor point to clear up and submit! #

Powered by Twitter Tools

• When it comes to venture capital companies, they stipulate a method of contact but in all honesty get on the phone! #
• Data exclusivity is an important element of IP associated with drug development, easpecialy when re-purposing a generic drug. #
• Attention to detail is absolutley essential when compiling a regulatory document. Confusion needs to be avoided at all costs! #

Powered by Twitter Tools

• Preperation is the key to success, without it you will feel disjointed! #
• USA FDA has some very truncated regulatory pathways for common otc products! #
• Change of route can impact on a develpoment programme to the extent to which PK/PD is impacted! #
• Working on a business plan for a client, so many data inputs required! #
• When is a device not a device, when its an advanced therapy medical technology! #
• We provide a drug regulatory watch service for free sign up at our website http://www.damienbove.com #

Powered by Twitter Tools

• Preperation is the key to success, without it you will feel disjointed! #
• USA FDA has some very truncated regulatory pathways for common otc products! #
• Change of route can impact on a develpoment programme to the extent to which PK/PD is impacted! #
• Working on a business plan for a client, so many data inputs required! #
• When is a device not a device, when its an advanced therapy medical technology! #
• We provide a drug regulatory watch service for free sign up at our website http://www.damienbove.com #

Powered by Twitter Tools

• MHRA product registration documentation, is very much a case be case affair, but case by case is what we do. #
• Having a network of consultants reduces costs for clients who don't have an underutilised infrastcucture to maintain. #

Powered by Twitter Tools

• What training to tech transfer and commercialisation officers get and is it adequate? A question we intend to ask, and build our product to! #
• Investments can be a big numbers game, sometimes a fit can be difficult, then you have to try and try and try. 180 vc firms on my list #

Powered by Twitter Tools

• Indication selection don't just look at mechanuism of action, think about you usp too! #
• Knowing how to get information out of the regulators can often be a simple case of asking for it. #
• Technical files for devices rely heavily on the classification, this needs to be established on a case by case basis. #
• Sometimes with market research the data requires such a small amount of interpritation clients just don't need you to provide it! #

Powered by Twitter Tools

• Market access issues are central to indication selction and central to market access is an understanding of the treatment pathways #
• Wow the drug/biotech regulations change so quickley. Go to damienbove.com for our free regulatory watch service. #
• Desk research in medical technologies from 350per day. Markets, deals, suppliers, liturature, people, companies, or anything you want #
• We won a yorkshire forward award for excellence in mentoring new start up businesses. A great reflection on our work #

Powered by Twitter Tools

• DILI the FDA liver tox regulations take a pragmatic stance on liver tox. If your going to save your product you need our expert review #

Powered by Twitter Tools

• Orphan drug designations and stratifications, require demonstartion of plausibility in the target group, but also positive elimination! #
• Sme stauts with the EMEA attracts a 90% discount on scientific advice fees. #
• Ethis in phase 1 clinical research white paper launched on http://www.damienbove.com/medqp/ #

Powered by Twitter Tools

• Data is so important when getting regulatory advice and a broad bredth of data is best #
• Health economic modeling requires good data' poor data makes the task meaningless! #
• Orphan drug awards can be retracted at 6 years if your doing very well. #

Powered by Twitter Tools

• I have been off the grid with phone failure fortunatly everything is backed up. The lesson is reinforced. #
• When seaking venture capital investment for a biotch or pharma project selecting the right partners to approach is critical to success #

Powered by Twitter Tools

• Presenting a business plan is more than the science! And more than market sizes! Its alllll about dynamics! Its just so important! #

Powered by Twitter Tools

• Contracting out specific project elements to independent experts means we can offer a full service with high expertise in all areas! #
• Orphan presentations should include all that an orphan application contains! Emea and FDA combined applications! #
• Indication selection needs be be inclusive and broad if it is to make sense! #
• Ideas only have value when you implement and share Them and that goes double in science! But keep confidential until your patented! #

Powered by Twitter Tools

• Business opportunities present themselves frequentley. You have to be open to them! #

Powered by Twitter Tools